Researcher, Vascular Overviews Group
Kelly has a degree in Nutrition and Food Science from the University of Surrey (1996). After working as an analytical chemist for 10 years she completed a postgraduate certificate in epidemiology and joined CTSU in 2006. Initially working on large leukaemia trials such as UKALL XII and CLL4 Kelly moved to the Vascular Overviews Group (VOG) in 2010. She now works on large-scale meta-analyses such as those conducted by the Antithrombotic Treatment Trialists’ (ATT) and the Cholesterol Treatment Trialists’ (CTT) Collaborations.
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.
Pitcher A. et al, (2022), Lancet
Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy
BAIGENT C. et al, (2022), The Lancet
Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.
Cholesterol Treatment Trialists' Collaboration None., (2022), Clin Trials
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
Scally B. et al, (2018), Lancet Gastroenterol Hepatol, 3, 231 - 241